Sitemap
November 30, 2007 Articles
Filter by Available Specialty
- Experimental study suggests endostatin could be potential AMD treatment
- OPKO Health completes acquisition of Ophthalmic Technologies
- Senate probes Genentech's plan to limit sales of bevacizumab
- Study finds 12% rate of THA within 3 years after initial complaints of osteoarthritis pain
- Study: Candida isolates more common in endogenous vs. postop endophthalmitis